Skip to main content

Table 2 Total costs, LYs and QALYs of all interventions for HBeAg positive CHB patients aged 30 years old and above

From: A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

Interventions

Total costs (THB)§

LYs

QALYs

Incremental cost (THB)

Incremental QALYs

ICER per QALY gained

First drug (Second drug) Third drug

1. Generic lamivudine (tenofovir)†

456,000

20.87

13.66

-72,000

5.03

Dominant*

2. Generic lamivudine (tenofovir)‡

490,000

20.87

13.66

-38,000

5.03

Dominant*

3. Tenofovir monotherapy†

501,000

20.89

13.67

-26,000

5.04

Dominant*

4. Palliative care

527,000

13.13

8.63

-

-

-

5. Original lamivudine (tenofovir)†

937,000

20.87

13.66

409,000

5.03

81,000

6. Pegylated interferon (original lamivudine) tenofovir†

953,000

20.89

13.67

426,000

5.05

84,000

7. Original lamivudine (tenofovir)‡

971,000

20.87

13.66

444,000

5.03

88,000

8. Generic lamivudine (adefovir)†

982,000

20.87

13.66

454,000

5.03

90,000

9. Pegylated interferon (tenofovir)†

1,057,000

20.91

13.69

530,000

5.06

105,000

10. Telbivudine (tenofovir)†

1,091,000

20.90

13.68

564,000

5.05

112,000

11. Generic lamivudine (adefovir)‡

1,134,000

20.87

13.66

606,000

5.03

121,000

12. Telbivudine (tenofovir)‡

1,134,000

20.87

13.66

606,000

5.03

121,000

13. Pegylated interferon (original lamivudine) tenofovir†

1,325,000

20.89

13.67

798,000

5.05

158,000

14. Adefovir (generic lamivudine)†

1,364,000

20.85

13.64

837,000

5.01

167,000

15. Pegylated interferon (lamivudine) adefovir†

1,371,000

20.89

13.67

844,000

5.05

167,000

16. Telbivudine (adefovir)†

1,429,000

20.90

13.68

902,000

5.05

178,000

17. Pegylated interferon (telbivudine) tenofovir†

1,442,000

20.92

13.69

915,000

5.06

181,000

18. Original lamivudine (adefovir)†

1,463,000

20.87

13.66

936,000

5.03

186,000

19. Entecavir (tenofovir)†

1,519,000

20.88

13.67

991,000

5.04

197,000

20. Entecavir (adefovir)†

1,536,000

20.88

13.67

1,009,000

5.04

200,000

21. Adefovir (original lamivudine)†

1,564,000

20.85

13.64

1,037,000

5.01

207,000

22. Original lamivudine (adefovir)‡

1,616,000

20.87

13.66

1,088,000

5.03

216,000

23. Pegylated interferon (adefovir) generic lamivudine†

1,648,000

20.88

13.66

1,120,000

5.04

222,000

24. Telbivudine (adefovir)‡

1,657,000

20.90

13.68

1,130,000

5.05

224,000

25. Pegylated interferon (telbivudine) adefovir†

1,710,000

20.92

13.69

1,182,000

5.06

233,000

26. Pegylated interferon (original lamivudine) adefovir†

1,744,000

20.89

13.67

1,216,000

5.05

241,000

27. Pegylated interferon (entecavir) tenofovir†

1,771,000

20.90

13.68

1,243,000

5.05

246,000

28. Pegylated interferon (entecavir) adefovir†

1,785,000

20.90

13.68

1,257,000

5.05

249,000

29. Pegylated interferon (adefovir) original lamivudine†

1,812,000

20.88

13.66

1,284,000

5.04

255,000

  1. †Scenario 1: Adding drug when drug resistance occurred; ‡Scenario 2: Adding drug based on the road map guideline.
  2. §total costs are calculated in 2010 THB and rounded up to nearest 1,000 THB.
  3. *Negative ICER due to higher effectiveness and lower costs of intervention compared with palliative care.